Catia Giovannini

14PUBLICATIONS
42CO-AUTHORS
Predictive and prognostic markersMolecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Apr 27, 2026
Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma.

|May 07, 2025
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma.

Ilaria Leoni, Giuseppe Galvani, Elisa Monti

|Jan 08, 2025
Notch Signaling and PD-1/PD-L1 Interaction in Hepatocellular Carcinoma: Potentialities of Combined Therapies.

Annapaola Montagner, Andrea Arleo, Fabrizia Suzzi

|Jan 08, 2025
Multifaceted Aspects of Dysfunctional Myelopoiesis in Cancer and Therapeutic Perspectives with Focus on HCC.

Andrea Arleo, Annapaola Montagner, Catia Giovannini

|Feb 24, 2024
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response.

Clara Vianello, Elisa Monti, Ilaria Leoni

|Nov 22, 2023
Circulating CD8 lymphocytes predict response to atezolizumab-bevacizumab in hepatocellular carcinoma.

Laura Gramantieri, Fabrizia Suzzi, Cristian Bassi

Pageof 3

Frequent Collaborators

9 joint publications

Francesca Fornari

9 joint publications

Fabio Piscaglia

8 joint publications

Laura Gramantieri

3 joint publications

Davide Trerè